Why I Recommend Hepatitis B Vaccination to All My Patients

COMMENTARY

Why I Recommend Hepatitis B Vaccination to All My Patients

Sandra Adamson Fryhofer, MD

Disclosures

May 03, 2022

0

Editor’s Note: This report has been updated to reflect information on hepatitis B vaccines that became available after the video was recorded.

This transcript has been edited for clarity.

Hello. I'm Dr Sandra Fryhofer. Welcome to Medicine Matters. The topic: the new hepatitis B vaccination recommendations for 2022. Here's why it matters.

Each year, more than 20,000 people in the United States contract acute hepatitis B, with healthcare costs of more than a billion dollars. As many as 40% of them have complications. Hepatitis B can lead to chronic hepatitis infection and liver cancer, and 15%-25% of those infected will die prematurely of cirrhosis or liver cancer. This is needless suffering and death.

Hepatitis B infection is vaccine preventable. We have several vaccine versions to choose from, and they work. The older, three-dose hepatitis B vaccine preparations are more than 90% protective. Immunity is durable, lasting at least three decades.

Two newer vaccines are now available, but only for those aged 18 or older. One of them, Heplisav, contains a new adjuvant, CpG 1018. Its two-dose series can be completed in just 1 month.

A new triple-target hepatitis B vaccine, PreHevbrio, was FDA-approved in December 2021. It requires three doses in a series and contains three hepatitis B antigens.

Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....